Answer
Breastfeeding should be discontinued throughout glofitamab (Columvi) treatment and for 2 months after the final dose.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked